Allometric basis of enrofloxacin scaling in green iguanas

Journal of Veterinary Pharmacology and Therapeutics

Volumn 31, Issue 1, 2008, Pages 9-17

  Maxwell, L K ^a,b   Jacobson, E R ^c  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b Department of Physiological Sciences ^*

^c University of Florida College of Veterinary Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENROFLOXACIN; PENTETATE TECHNETIUM TC 99M;

ALLOMETRY; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BODY SIZE; BODY SURFACE; BODY WEIGHT; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; KIDNEY CLEARANCE; LIZARD; MALE; METABOLIC RATE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; FEMALE; FLUOROQUINOLONES; IGUANAS; INFUSIONS, INTRAVENOUS; KIDNEY; MALE; METABOLIC CLEARANCE RATE; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M PENTETATE;

IGUANA IGUANA; IGUANIA;

EID: 37549037874     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00915.x     Document Type: Article

References (45)

1. Anderson, B.J., Allegaert, K. Holford, N.H.G. (2006) Population clinical pharmacology of children: modelling covariate effects. European Journal of Pediatrics, 165, 819 829.
2. Andrews, R.A. Pough, F.H. (1985) Metabolism of squamate reptiles: allometric and ecological relationships. Physiological Zoology, 58, 214 231.
3. Baker, S.D. Sparreboom, A. (2006) Predicting vinorelbine disposition and toxicity: does BSA provide more than a "bad statistical association"? Journal of Clinical Oncology, 24, 2412 2413.
4. Bermingham, E., Papich, M. Vivrette, S. (2000) Pharmacokinetics of enrofloxacin administered intravenously and orally to foals. American Journal of Veterinary Research, 61, 706 709.
5. Boxenbaum, H. Dilea, C. (1995) First-time-in-human dose selection - allometric thoughts and perspectives. Journal of Clinical Pharmacology, 35, 957 966.
6. Boxenbaum, H. Ronfeld, R. (1983) Interspecies pharmacokinetic scaling and the Dedrick plots. American Journal of Physiology, 245, R768 R775.
7. Bregante, M.A., Saez, P., Aramayona, J.J., Fraile, L., Garcia, M.A. Solans, C. (1999) Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep, and cows. American Journal of Veterinary Research, 60, 1111 1116.
8. Brody, S., Procter, R. Ashworth, U. (1934) Basal metabolism, endogenous nitrogen, creatinine and neutral sulphur excretions as functions of body weight. University of Missouri Agricultural Experimental Station Residential Bulletin, 220, 1 40.
9. Caldwell, G.W., Masucci, J.A., Yan, Z. Hageman, W. (2004) Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data? European Journal of Drug Metabolism and Pharmacokinetics, 29, 133 143.
10. Calvert, A.H., Newell, D.R., Gumbrell, L.A., O'Reilly, S., Burnell, M., Boxall, F.E., Siddik, Z.H., Judson, I.R., Gore, M.E. Wiltshaw, E 1989) Carboplatin dosage: prospective evaluation of a simple formula based on renal function. Journal of Clinical Oncology, 7, 1748 1756.
11. Cox, S.K., Cottrell, M.B., Smith, L., Papich, M.G., Frazier, D.L. Bartges, J. (2004) Allometric analysis of ciprofloxacin and enrofloxacin pharmacokinetics across species. Journal of Veterinary Pharmacology and Therapeutics, 27, 139 146.
12. Dedrick, R.L., Bischoff, K.B. Zaharko, D.S. (1970) Interspecies correlation of plasma concentration history of methotrexate. Cancer Chemotherapy Reports. Part 1, 54, 95 101.
13. Gardner, S.Y. Papich, M.G. (2001) Comparison of cefepime pharmacokinetics in neonatal foals and adult dogs. Journal of Veterinary Pharmacology and Therapeutics, 24, 187 192.
14. Gibaldi, M. Perrier, D. (1982) Pharmacokinetics. Marcel Dekker, New York.
15. Goodisman, J. Souid, A.K. (2006) Constancy in integrated cisplatin plasma concentrations among pediatric patients. Journal of Clinical Pharmacology, 46, 443 448.
16. Hemmingsen, A.M. (1960) Energy metabolism as related to body size and respiratory surfaces, and its evolution. Reports of the Steno Memorial Hospital and the Nordisk Insulin-Laboratorium (Copenhagen), 9, 1 95.
17. Heusner, A.A. (1982) Energy metabolism and body size. II. dimensional analysis and energetic non-similarity. Respiration Physiology, 48, 13 25.
18. Johnson, T.N., Rostami-Hodjegan, A. Tucker, G.T. (2006) Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children. Clinical Pharmacokinetics, 45, 931 956.
19. Kleiber, M. (1947) Body size and metabolic rate. Physiological Reviews, 27, 511 541.
20. Kleiber, M. (1961) The Fire of Life. Wiley, New York.
21. Lam, F., Hung, C. Perrier, D. (1985) Estimation of variance for harmonic mean half-lives. Journal of Pharmaceutical Sciences, 74, 229 231.
22. Loos, W.J., de Jongh, F.E., Sparreboom, A., de Wit, R., van Boven-van Zomeren, D.M., Stoter, G., Nooter, K. Verweij, J. (2006) Evaluation of an alternate dosing strategy for cisplatin in patients with extreme body surface area values. Journal of Clinical Oncology, 24, 1499 1506.
23. Mahmood, I. (1998) Interspecies scaling: predicting volumes, mean residence time and elimination half-life. Some suggestions. Journal of Pharmacy and Pharmacology, 50, 493 499.
24. Mahmood, I. (2006) Prediction of drug clearance in children from adults: a comparison of several allometric methods. British Journal of Clinical Pharmacology, 61, 545 557.
25. Mahmood, I., Martinez, M. Hunter, R.P. (2006) Interspecies allometric scaling. Part I: prediction of clearance in large animals. Journal of Veterinary Pharmacology and Therapeutics, 29, 415 423.
26. Maxwell, L.K. Jacobson, E.R. (2004) Allometric scaling of kidney function in green iguanas. Comparative Biochemistry and Physiology. Part A, Molecular and Integrative Physiology, 138, 383 390.
27. Maxwell, L.K., Jacobson, E.R. McNab, B.K. (2003) Intraspecific allometry of standard metabolic rate in green iguanas, Iguana iguana. Comparative Biochemistry and Physiology. A, Comparative Physiology, 136, 301 310.
28. Mordenti, J. (1986) Man versus beast: pharmacokinetic scaling in mammals. Journal of Pharmaceutical Sciences, 75, 1028 1040.
29. Pinkel, D. (1958) The use of body surface area as a criterion of drug dosage in cancer chemotherapy. Cancer Research, 18, 853 856.
30. Price, G.S. Frazier, D.L. (1998) Use of body surface area (BSA)-based dosages to calculate chemotherapeutic drug dose in dogs: I. Potential problems with current BSA formulae. Journal of Veterinary Internal Medicine, 12, 267 271.
31. Prothero, J.W. (1982) Organ scaling in mammals: the liver. Comparative Biochemistry and Physiology. A, Comparative Physiology, 71, 567 577.
32. Prothero, J.W. (1984) Organ scaling in mammals: the kidneys. Comparative Biochemistry and Physiology. A, Comparative Physiology, 77, 133 138.
33. Ritschel, W.A., Vachharajani, N.N., Johnson, R.D. Hussain, A.S. (1992) The allometric approach for interspecies scaling of pharmacokinetic parameters. Comparative Biochemistry and Physiology. C: Comparative Pharmacology, 103, 249 253.
34. Riviere, J.E., Martin-Jimenez, T., Sundlof, S.F. Craigmill, A.L. (1997) Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species. Journal of Veterinary Pharmacology and Therapeutics, 20, 453 463.
35. Sedgwick, C.J., Moffat, S. Kollias, G.V. (1984) Scaling antimicrobial drug dosage regimens to minimum energy cost rather than body weight. Proceeding of American Association of Zoo Veterinarians, pp. 15 20, Louisville, KY.
36. Seguin, M.A., Papich, M.G., Sigle, K.J., Gibson, N.M. Levy, J.K. (2004) Pharmacokinetics of enrofloxacin in neonatal kittens. American Journal of Veterinary Research, 65, 350 356.
37. Shim, H.J., Kim, Y.C., Lee, J.H., Kwon, J.W., Kim, W.B., Kim, Y.G., Kim, S.H. Lee, M.G. (2005) Interspecies pharmacokinetic scaling of DA-8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics. Biopharmaceutics and Drug Disposition, 26, 269 277.
38. Smorenburg, C.H., Sparreboom, A., Bontenbal, M., Stoter, G., Nooter, K. Verweij, J. (2003) Randomized cross-over evaluation of body-surface area-based dosing versus flat-fixed dosing of paclitaxel. Journal of Clinical Oncology, 21, 197 202.
39. Sokal, R.R. Rohlf, F.J. 1981) Biometry. The Principles and Practice of Statistics in Biological Research. W.H. Freeman and Co, New York.
40. Sparreboom, A. (2005) BSA-based dosing and alternative approaches. Clinical Advances in Hematology and Oncology, 3, 448 450.
41. Thorson, T. (1968) Body fluid partitioning in Reptilia. Copeia, 3, 592 601.
42. West, G.B., Brown, J.H. Enquist, B.J. (1997) A general model for the origin of allometric scaling laws in biology. Science, 276, 122 126.
43. Wiewandt, T.A. (1982) Evolution of nesting patterns in Iguanine lizards. In Iguanas of the World. Their Behavior, Ecology, and Conservation. Eds Burghardt, G.M. Rand, A.S., pp. 119 141. Noyes Publication, Park Ridge, NJ.
44. Yamamoto, N., Tamura, T., Murakami, H., Shimoyama, T., Nokihara, H., Ueda, Y., Sekine, I., Kunitoh, H., Ohe, Y., Kodama, T., Shimizu, M., Nishio, K., Ishizuka, N. Saijo, N. (2005) Randomized pharmacokinetic and pharmacodynamic study of docetaxel: dosing based on body-surface area compared with individualized dosing based on cytochrome P450 activity estimated using a urinary metabolite of exogenous cortisol. Journal of Clinical Oncology, 23, 1061 1069.
45. Young, L.A., Schumacher, J., Papich, M.G. Jacobson, E.R. (1997) Disposition of enrofloxacin and its metabolite ciprofloxacin after intravascular injection in juvenile Burmese pythons (Python molurus bivittatus). Journal of Zoo and Wildlife Medicine, 28, 71 79.